Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013 Earnings Call Slated for February 14, 6.30 PM IST / 8.00 AM EST* Business Wire HYDERABAD, India -- February 6, 2013 Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter and Nine months ended December 31, 2012 on Thursday, February 14, 2013 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com. Summary of Events Event Date and Time (IST) Medium Release of financial February 14th, after the Email, Media, Company results Board Meeting website, Business Wire February 14th, 6.30 PM IST Hosted by the Company Earnings Call / 8.00 AM EST (Details below) February 14th, 6.30 PM IST URL available on Company’s Webcast of Earnings / 8.00 AM EST through website, Call February 19th, 2013 www.drreddys.com Transcripts of the Will be available on the URL available on Company’s Earnings call Company’s website website, www.drreddys.com Earnings Call Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance. Conference Dial-In Numbers Primary Number: +91 22 3065 0136 Secondary Number: +91 22 6629 0356 The numbers listed above are universally accessible from all networks and all countries. 6000 1221 Available in - Ahmedabad, Bangalore, Chennai, Cochin, Delhi (NCR), Hyderabad, Kolkata, Lucknow Local Access Number: Accessible from all major carriers except BSNL/MTNL. 3940 3977 Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune Accessible from all carriers. USA: 1 866 746 2133 International Toll Free UK: 0 808 101 1573 Number: Singapore: 800 101 2045 Hong Kong: 800 964 448 No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call. Audio Webcast The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through Feb 19th, 2013. For play back dial in phone No: 022 3065 1212 and ID: 375#. Transcript The transcript of the earnings call will also be available on the Company's website. About Dr. Reddy’s Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com. *EST- Eastern Standard Time Contact: Dr. Reddy’s Laboratories Ltd. Investor Relations: Kedar Upadhye, +91 40 66834297 email@example.com or Saunak Savla, +91 40 49002135 firstname.lastname@example.org or Milan Kalawadia (USA), +1 9082034931 email@example.com
Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013
Press spacebar to pause and continue. Press esc to stop.